Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) Return on equity
Cencora, Inc.'s return on equity over the twelve months to 30 June 2026 was 96.3%, down 26.3 percentage points from fiscal 2025 (122.7%). Over the past ten years it has ranged from −1,206.7% (fiscal 2021) to 518.2% (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 122.7% | (85.05) |
| FY2024 | 207.7% | (265.54) |
| FY2023 | 473.3% | (44.92) |
| FY2022 | 518.2% | 1,724.91 |
| FY2021 | −1,206.7% | (890.17) |
| FY2020 | −316.6% | (344.87) |
| FY2019 | 28.3% | (36.54) |
| FY2018 | 64.9% | 47.47 |
| FY2017 | 17.4% | (86.63) |
| FY2016 | 104.0% | 114.75 |
Against its own ten years
Low −1,206.7%
High 518.2%
Ten-year median
64.9%
Current reading's percentile
73
Return on equity against peers
| Company | Return on equity |
|---|---|
| COR Cencora, Inc. | 96.3% |
| ACH Accendra Health, Inc. compare | 72.6% |
| YI 111, Inc. Sponsored ADR compare | 12.3% |
| HSIC Henry Schein, Inc. compare | 10.2% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| CAH Cardinal Health, Inc. compare | −64.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation compare | −168.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement